Location History:
- Germantown, MD (US) (2006)
- Westchester, PA (US) (2010 - 2012)
Company Filing History:
2 out of 1,036 
1 out of 549 
Years Active: 2006-2012
Title: Innovations and Contributions of John Rougas
Introduction
John Rougas is an accomplished inventor based in West Chester, Pennsylvania. He holds three patents that showcase his significant contributions to the field of medicinal chemistry. His work primarily focuses on the synthesis of important pharmaceutical compounds that have the potential to treat serious health conditions.
Latest Patents
Among his latest patents is the "Synthesis of 4-amino-thalidomide enantiomers." This invention provides new and useful analogs of 4-amino-thalidomide, including S(−)-4-amino-thalidomide and R(+)-4-amino-thalidomide. The patent also outlines processes for making these analogs. Furthermore, it presents methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, such as cancer and macular degeneration, by administering these compounds. Another patent, titled "Method of synthesis of 4-amino-thalidomide enantiomers," reiterates the significance of these analogs and their potential therapeutic applications.
Career Highlights
John Rougas has worked with notable organizations, including Children's Medical Center Corporation and Celgene Corporation. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Some of his coworkers include Jamshed H Shah and Barry P Conner. Their collaboration has likely fostered an environment of creativity and innovation, leading to the development of impactful inventions.
Conclusion
John Rougas's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents not only highlight his expertise but also contribute to the ongoing fight against serious diseases. His contributions are a testament to the importance of research and development in improving healthcare outcomes.